SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Protect Pharmaceutical Corporation PRTT OTC

Other OTC • Industrials • Conglomerates • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Protect Pharmaceutical Corporation (PRTT) is a Conglomerates company in the Industrials sector, currently trading at $0.05. It has a SharesGrow Score of 90/100, indicating a strong investment profile with 5 out of 7 criteria passed.

Financials: revenue is $132M, +22.5%/yr average growth. Net income is $56M, growing at +46.1%/yr. Net profit margin is 42.6% (strong). Gross margin is 54.9% (-1.4 pp trend).

Balance sheet: total debt is $4M against $333M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.06 (strong liquidity). Debt-to-assets is 0.9%. Total assets: $418M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 54/100 (Partial), Future ?/100 (Fail), Income 100/100 (Pass).

PRTT SharesGrow Score Overview

92/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 54/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PRTT

PRTT trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

PRTT: +22.5%/yr revenue is, +46.1%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

PRTT: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet PRTT: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 3.06 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

PRTT: Gross margin is 54.9% (-1.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

PRTT: Net profit margin is 42.6%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.018-1.5

Volume30K

Avg Volume (30D)7.62K

Market Cap$2.87M

Beta (1Y)2.91

Share Statistics

EPS (TTM)0.98

Shares Outstanding$57.45M

IPO Date2006-08-01

CEOAlan Crooks

Financial Highlights & Ratios

Revenue (TTM)$132.26M

Gross Profit$72.56M

EBITDA$57.64M

Net Income$56.33M

Operating Income$57.64M

Total Cash$73.94M

Total Debt$3.83M

Net Debt$-13.83M

Total Assets$417.63M

Price / Earnings (P/E)0.1

Price / Sales (P/S)0.02

Analyst Forecast

Company Info

CountryUS

ExchangeOther OTC

CurrencyUSD

ISINUS74364W2035

Price Chart

PRTT

Protect Pharmaceutical Corporation ↗ · Other OTC

Industrials • Conglomerates

0.02 52WK RANGE 1.50

People Also View

Global Tech Industries Group, Inc.

Moon Equity Holdings Corp.

1847 Holdings LLC

Global Technologies, Ltd.

Exxe Group Inc.

Universal Power Industry Corporation

Gaensel Energy Group, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message